Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm
- Barrio, S.
- Gallardo, M.
- Arenas, A.
- Ayala, R.
- Rapado, I.
- Rueda, D.
- Jimenez, A.
- Albizua, E.
- Burgaleta, C.
- Gilsanz, F.
- Martinez-Lopez, J.
ISSN: 0007-1048, 1365-2141
Argitalpen urtea: 2013
Alea: 161
Zenbakia: 5
Orrialdeak: 667-676
Mota: Artikulua